The World Health Organization International Classification of Functioning, Disability, and Health: a model to guide clinical thinking, practice and research in the field of cerebral palsy

The way we think about health and disease determines to a considerable extent what we do and say in our clinical encounters with patients. The recent publication and promotion of the World Health Organization's International Classification of Function, Health, and Disability (known as the ICF) represents an exciting new way to consider health and disease. In the context of children and youth with cerebral palsy, this model offers many heretofore ignored "point of entry" for counselling and intervention with these conditions. This model also provides many possibilities to explore research questions with a fresh approach. This article outlines the ICF model and discusses these opportunities.     

Effects of a transdiagnostic group treatment for anxiety on secondary depression

Researchers have recently explored transdiagnostic anxiety treatments based on models of anxiety emphasizing a single common pathway across diagnostic categories. Results from a previous study [Norton and Hope, in press] indicated that a transdiagnostic approach was effective for both targeted and untargeted anxiety disorders. Consistent with the tripartite model, the transdiagnostic treatment should also influence symptoms of a broader pathology such as negative affectivity. This follow-up to Norton and Hope found significant decreases in depressed mood for clients undergoing transdiagnostic treatment for anxiety when compared to wait-list control participants. Although not statistically established, severity of depressive diagnoses seemed to generally decrease across treatment, whereas no change in severity occurred for those not receiving treatment.     

Pulmonary tumorlets: CT findings

OBJECTIVE: Pulmonary tumorlets are defined in pathologic terms as benign localized neuroendocrine cell proliferations a few millimeters in size that are usually associated with damaged and ectatic small airways. The purpose of this study was to determine the frequency with which pulmonary tumorlets can be seen on CT and to describe their CT appearance. CONCLUSION: In 33 patients with proven tumorlets, a nodule was visible on CT in the same region as that of the resected specimen. Despite its ominous-sounding name, a pulmonary tumorlet represents benign tissue that may manifest as a subcentimeter pulmonary nodule and should be considered in the differential diagnosis of small pulmonary nodules visible on CT.